Richard Bernstein Advisors LLC Has $1.08 Million Position in Cigna Group $CI

Richard Bernstein Advisors LLC reduced its stake in Cigna Group (NYSE:CI) by 50.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,742 shares of the health services provider’s stock after selling 3,829 shares during the period. Richard Bernstein Advisors LLC’s holdings in Cigna Group were worth $1,079,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Norges Bank bought a new position in shares of Cigna Group during the 2nd quarter worth approximately $1,110,426,000. Capital Research Global Investors raised its stake in shares of Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after purchasing an additional 1,855,897 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Cigna Group by 24.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after buying an additional 492,045 shares during the last quarter. Balyasny Asset Management L.P. boosted its holdings in shares of Cigna Group by 1,057.2% in the 2nd quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after buying an additional 369,775 shares during the last quarter. Finally, Man Group plc grew its position in Cigna Group by 215.5% during the second quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after buying an additional 363,510 shares during the period. 86.99% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on CI shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th. UBS Group reiterated a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Robert W. Baird lowered their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $330.42.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Stock Down 2.8%

Shares of CI stock opened at $262.13 on Wednesday. The company’s fifty day moving average price is $280.29 and its 200-day moving average price is $283.45. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a market capitalization of $69.08 billion, a price-to-earnings ratio of 11.82, a PEG ratio of 0.93 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same period last year, the firm posted $6.64 EPS. The company’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.4%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is presently 28.13%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.